Praveen P. Govender, MB BCh
Assistant Professor, Medicine
Biography
Dr. Praveen Govender is the Associate Director of the Sarcoidosis Center with training in Pulmonary Medicine, Allergy and Immunology. He has worked extensively with Dr. Jeffrey Berman in the care of patients with sarcoidosis since 2008 at The Sarcoidosis Center at Boston Medical Center. Their mission is to improve the lives of persons with sarcoidosis by providing state-of-the-art patient care coupled with innovative research aimed at understanding the pathogenesis and natural history of sarcoidosis. Dr. Govender is an active member of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG).
Other Positions
- Member, Pulmonary Center, Boston University
Education
- Royal College of Surgeons in Ireland, MBBCh
- University of Alberta, BS
Publications
- Published on 11/1/2022
Cozier YC, Govender P, Berman JS. Obesity and Sarcoidosis Risk: An Index Under Suspicion. Chest. 2022 Nov; 162(5):954-956. PMID: 36344120.
Read at: PubMed - Published on 2/22/2021
Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med. 2022 Apr; 37(4):441-458. PMID: 33611981.
Read at: PubMed - Published on 10/1/2020
Law ST, Jafarzadeh SR, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 10; 72(10):1466-1473. PMID: 31309727.
Read at: PubMed - Published on 9/3/2020
Govender P, Cozier YC. Sarcoidosis in a time of pandemic. Eur Respir J. 2020 09; 56(3). PMID: 32883761.
Read at: PubMed - Published on 6/30/2020
Abston E, Moll M, Hon S, Govender P, Berman J, Farber H. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):184-191. PMID: 33093782.
Read at: PubMed - Published on 6/30/2020
Abston E, Hon S, Lawrence R, Berman J, Govender P, Farber HW. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):234-238. PMID: 33093789.
Read at: PubMed - Published on 6/30/2020
Nitzberg M, Parikh R, Govender P, Farber HW. Pulmonary hypertension secondary to takayasu's arteritis: management using a combined medical and interventional approach. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):239-241. PMID: 33093790.
Read at: PubMed - Published on 4/15/2020
Cozier YC, Govender P. Sarcoidosis: An Ill-afforded Disease. Am J Respir Crit Care Med. 2020 04 15; 201(8):890-891. PMID: 31978312.
Read at: PubMed - Published on 4/15/2020
Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 04 15; 201(8):e26-e51. PMID: 32293205.
Read at: PubMed - Published on 9/1/2018
Cozier YC, Govender P, Berman JS. Obesity and sarcoidosis: consequence or contributor? Curr Opin Pulm Med. 2018 09; 24(5):487-494. PMID: 29979212.
Read at: PubMed
View 12 more publications: View full profile at BUMC